Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Jan;15(1):37-44.
doi: 10.1007/s12603-011-0011-y.

Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life

M Rondanelli  1 , A Giacosa, A Opizzi, C Pelucchi, C La Vecchia, G Montorfano, M Negroni, B Berra, P Politi, A M Rizzo
Affiliations
Randomized Controlled Trial

Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life

M Rondanelli et al. J Nutr Health Aging. 2011 Jan.

Abstract

Objective: Recent observations showed that long chain omega 3 polyunsaturated fatty acids (n-3 LCPUFA) could represent a potential treatment for elderly depression. To determine if a n-3 LCPUFA containing supplement improves depressive symptoms, changes phospholipids acids profile and ameliorates Health related quality of life (HRQoL) in depressed elderly patients.

Design: Two-months, randomized, double-blind, placebo-controlled trial.

Setting: Nursing home in Pavia, Italy.

Subjects: Forty-six depressed females, aged 66-95 years.

Intervention: 22 depressed females were included in the intervention group (n-3 group, that received 2.5 g/day of n-3 LCPUFA, with 1.67 grams of EPA and 0.83 grams of DHA), and 24 patients in the placebo group. The primary endpoint was the improvement of depressive symptoms as evaluated by Geriatric Depression Scale (GDS). Secondary endpoints were the evaluation of modifications of erythrocyte membrane phospholipids fatty acid profile and of of HRQoL, by using the Short-Form 36-Item Health Survey (SF-36). All parameters were assessed before and after the treatment period of 8 weeks.

Results: The mean GDS at 2 months was significantly lowered only for the n-3 group. SF-36 physical and mental components were significantly increased in the intervention group. Compliance was good, as confirmed by erythrocyte membrane phospholipid FA concentrations, with significant increase of EPA and DHA in the intervention group.

Conclusion: The supplementation of n-3 LCPUFA in elderly female patients reduces the occurrence of depressive symptoms, improves phospholipids fatty acids profile and health-related quality of life.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of a trial of supplementation with LCPUFA n-3 versus placebo in the treatment of elderly patients affected by depression. The diagram includes the number of patients analysed for the main outcome (effect on depressed mood)
See this image and copyright information in PMC

References

    1. Beekman A.T., Copeland J.R., Prince M.J. Review of community prevalence of depression in later life. Br J Psychiatry. 1999;174:307–311. 10.1192/bjp.174.4.307 10533549. - DOI - PubMed
    1. Olin J.T., Schneider L.S., Katz I.R., Meyers B.S., Alexopoulos G.S., Breitner J.C., Bruce M.L., Caine E.D., Cummings J.L., Devanand D.P., Krishnan K.R., Lyketsos C.G., Lyness J.M., Rabins P.V., Reynolds C.F., 3rd, Rovner B.W., Steffens D.C., Tariot P.N., Lebowitz B.D. Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry. 2002;10:125–128. 11925273. - PubMed
    1. Pearson J.L., Conwell Y. Suicide in late life: challenges and opportunities for research. Int Psychogeriatr. 1995;7:131–136. 10.1017/S104161029500192X 8829422. - DOI - PubMed
    1. Pearson J.L., Brown G.K. Suicide prevention in late life: directions for science and practice. Clin Psychol Rev. 2000;20:685–705. 10.1016/S0272-7358(99)00066-5 10983264. - DOI - PubMed
    1. Sonnenberg C.M., Deeg D.J., Comijs H.C., van Tilburg W., Beekman A.T. Trends in antidepressant use in the older population: results from the LASA-study over a period of 10 years. J Affect Disor. 2008;111:299–305. 10.1016/j.jad.2008.03.009 - DOI - PubMed

Publication types